A Comparative evaluation of Conventional and Telephonic intervention for smoking cessation among rural population of Mappedu, Thiruvallur district,Tamil Nadu.

Main Article Content

Sathya Kumaresan
Meignana Arumugham Indiran
D.Sri Sakthi


Community approach, smoking cessation, rural population


Background: Rural areas present a higher prevalence of tobacco than the urban areas of India. However, village based smoking cessation intervention has the potential to assist in smoking cessations in communities unlike the tobacco cessation clinics in the urban settings. The present study is aimed to assess the effectiveness of smoking cessation interventions among the rural population of Mappedu, Thiruvallur district, Tamil Nadu.
Materials and Methods: Current daily smoking residents in the age group of 20-80 years were allocated to conventional group and telephone groups of smoking cessation interventions.Self reported abstinence was assessed at 1st month and 6th month follow up intervals.
Results: An increased percentage (50.76%) of study participants in the telephonic group remained abstinent as compared to the conventional group (44.96%) in the 1st month follow up.A majority (67.93%) of study participants in the telephonic group remained abstinent as compared to the conventional group (60%) in the 6th month follow up.
Conclusion: Multimodal behavioral approaches for smoking cessation programmes can motivate people to quit smoking in rural areas.

Abstract 106 | PDF Downloads 108


1. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. World Health Organization; 2008. 342 p.
2. Gurung MS, Pelzom D, Dorji T, Drukpa W, Wangdi C, Chinnakali P, et al. Current tobacco use and its associated factors among adults in a country with comprehensive ban on tobacco: findings from the nationally representative STEPS survey, Bhutan, 2014. Popul Health Metr. 2016 Aug 8;14:28.
3. Garcia NP, Gamboa AJGG 2nd, Ganzalino CMC, Garcia DC, Garcia GEC, Torres GCS. Predisposing, Reinforcing, and Enabling Factors of Nicotine Dependence Among Young Adults in a Rural Community. J Addict Nurs. 2023;34(1):55–63.
4. United States. Public Health Service. Office of the Surgeon General. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. U.S. Government Printing Office; 2012. 928 p.
5. McLeary JG, Walcott G, Abel W, Mitchell G, Lalwani K. Prevalence, perceived risk and associated factors of tobacco use amongst young, middle-aged and older adults: analysis of a national survey in Jamaica. Pan Afr Med J. 2022 Dec 8;43:185.
6. Zawertailo L, Zhang H, Rahmani N, Rajji TK, Selby P. Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial. PLoS One. 2022 Dec 8;17(12):e0277408.
7. Schell C, Godinho A, Cunningham JA. Learning to quit: can reinforcement theories predict the success of smoking cessation attempts using nicotine replacement therapy patches in a general population sample of smokers at 8-weeks and 6-months follow-up? Psychol Health Med. 2022 Oct 6;1–12.
8. Chu S, Feng L, Zuo Y, Jing H, Zhang D, Tong Z, et al. Evaluation of an innovative mHealth-based integrated modality for smoking cessation in Chinese smokers: protocol for a randomized controlled trial. BMC Public Health. 2023 Mar 25;23(1):561.
9. Xu M, Guo K, Shang X, Zhou L, E F, Yang C, et al. Network Meta-analysis of Behavioral Programs for Smoking Quit in Healthy People. Am J Prev Med [Internet]. 2023 Mar 7; Available from: http://dx.doi.org/10.1016/j.amepre.2023.02.032
10. Lin H, Liu Y, Zhang H, Zhu Z, Zhang X, Chang C. Assessment of a Text Message-Based Smoking Cessation Intervention for Adult Smokers in China: A Randomized Clinical Trial. JAMA Netw Open. 2023 Mar 1;6(3):e230301.
11. Leventakou V, Al Thani M, Sofroniou A, Butt HI, Eltayeb SM, Hakim IA, et al. Feasibility and Acceptability of a Telephone-Based Smoking Cessation Intervention for Qatari Residents. Int J Environ Res Public Health [Internet]. 2022 Dec 8;19(24). Available from: http://dx.doi.org/10.3390/ijerph192416509
12. Kim SS, Darwish S, Lee SA, Sprague C, DeMarco RF. A randomized controlled pilot trial of a smoking cessation intervention for US women living with HIV: telephone-based video call vs voice call. Int J Womens Health. 2018 Sep 25;10:545–55.
13. Schaal T, Schneiderat G, Rentzsch K, Geithner S. [Knowledge and perceptions of the population on services in case of need for long-term care: A standardized telephone survey]. Pflege. 2022 Aug;35(4):243–51.
14. Schuck K, Otten R, Kleinjan M, Bricker JB, Engels RCME. Effectiveness of proactive telephone counselling for smoking cessation in parents: study protocol of a randomized controlled trial. BMC Public Health. 2011 Sep 26;11:732.
15. Shariful Islam M, AlWajeah H, Rabbani MG, Ferdous M, Mahfuza NS, Konka D, et al. Prevalence of and factors associated with tobacco smoking in the Gambia: a national cross-sectional study. BMJ Open. 2022 Jun 13;12(6):e057607.
16. Vance L, Glanville B, Ramkumar K, Chambers J, Tzelepis F. The effectiveness of smoking
cessation interventions in rural and remote populations: Systematic review and meta-analyses. Int J Drug Policy. 2022 Aug;106:103775.
17. Ramachandraiyer AKS. Smoking Cessation Intervention in a Rural Healthcare Setting in South-India: A Pilot Feasibility Study. 2020. 550 p.
18. Cheng L, Ji N, Xu JW, Jia AN, Liang XF, Wu J. [Study on the willingness to quit smoking and its influencing factors among current smokers in rural areas in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Dec 10;43(12):1887–92.
19. K AP, Selvakumar SC, Selvaraj J, Mony U, Veeraraghavan VP, Sekar D, et al. Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics. Oral Oncol. 2022 Feb;125:105713.
20. Arshad S, Tehreem F, Rehab Khan M, Ahmed F, Marya A, Karobari MI. Platelet-Rich Fibrin Used in Regenerative Endodontics and Dentistry: Current Uses, Limitations, and Future Recommendations for Application. Int J Dent. 2021 Dec 15;2021:4514598.
21. Khandagale PD, Shetty PP, Makandar SD, Bapna PA, Karobari MI, Marya A, et al. Evaluation of Cyclic Fatigue of Hyflex EDM, Twisted Files, and ProTaper Gold Manufactured with Different Processes: An In Vitro Study. Int J Dent. 2021 Jul 29;2021:7402658.
22. Selvakumar SC, K Auxzilia P, Dinesh Y, Senthilmurugan M, Sekar D. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma. Oral Oncol. 2022 Jul;130:105925.
23. Gopinath D, Wie CC, Banerjee M, Thangavelu L, Kumar R P, Nallaswamy D, et al. Compositional profile of mucosal bacteriome of smokers and smokeless tobacco users. Clin Oral Investig. 2022 Feb;26(2):1647–56.
24. Bansal D, Kamboj M, Anand R, Pandiar D, Narwal A, Sivakumar N, et al. Association of childhood vaccination with pediatric lichen planus: A systematic review. Int J Dermatol. 2023 Jan;62(1):22–31.
25. Kurniawan A, Chusida A ’nisaa, Atika N, Gianosa TK, Solikhin MD, Margaretha MS, et al. The Applicable Dental Age Estimation Methods for Children and Adolescents in Indonesia. Int J Dent. 2022 Feb 15;2022:6761476.
26. Rekha K, Venkidasamy B, Govindasamy R, Neralla M, Thiruvengadam M. Isothiocyanates (AITC & BITC) bioactive molecules: Therapeutic potential for oral cancer. Oral Oncol. 2022 Oct;133:106060. 27. Selvaraj J, Yasothkumar D, Vishnu Priya V, Raj AT, Babu SD, Patil S. Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma. Oral Oncol. 2022 Jul;130:105922.
28. Balachander K, Roy A, Priyadharsini JV, Murugan S, Paramasivam A. Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer. Oral Oncol. 2022 May;128:105857.
29. Sinduja P, Ramani P, Gheena S, Ramasubramanian A. Expression of metallothionein in oral squamous cell carcinoma: A systematic review. J Oral Maxillofac Pathol. 2020 May 8;24(1):143–7.
30. Sekar AA, Veeraraghavan VP, Raj AT, Patil S. Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer. Oral Oncol. 2022 Dec;135:106195.
31. Chandralekha Selvakumar S, Auxzilia Preethi K, Sekar D. MicroRNAs and cancer-associated fibroblasts in the tumour microenvironment of oral squamous cell carcinoma (OSCC). Oral Oncol. 2022 Nov;134:106124.
32. Muthupandian S, Muralidharan M, Madhavan Y, Hariharan NM. Prospective role of salivary
MicroRNA for early detection - personalized therapy of head and neck squamous cell carcinoma. Oral Oncol. 2022 Nov;134:106063.
33. Sekaran S, Pitchaiah S, Ganapathy D. Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer? Oral Oncol. 2022 Aug;131:105973.
34. Jones SMW, Ton M, Heffner JL, Malen RC, Cohen SA, Newcomb PA. Association of financial worry with substance use, mental health, and quality of life in cancer patients. J Cancer Surviv [Internet]. 2023 Jan 3; Available from: http://dx.doi.org/10.1007/s11764-022-01319-4
35. Han B, Aung TW, Volkow ND, Silveira ML, Kimmel HL, Blanco C, et al. Tobacco Use, Nicotine Dependence, and Cessation Methods in US Adults With Psychosis. JAMA Netw Open. 2023 Mar 1;6(3):e234995.
36. Feldman I, Helgason AR, Johansson P, Tegelberg Å, Nohlert E. Cost-effectiveness of a high-intensity versus a low-intensity smoking cessation intervention in a dental setting: long-term follow-up. BMJ Open. 2019 Aug 15;9(8):e030934.